Laurie Gutmann

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Nosocomial Acquisition of Multiresistant Acinetobacter baumannii: Risk Factors and Prognosis

Olivier Lortholary, J.-Y. Fagon, Annie Buu Hoï et al. · Clinical Infectious Diseases · 1995 · 249 citations

Antimicrobial Susceptibility, Logistic Regression Analysis, Antibiotics +15

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban et al. · The Lancet Neurology · 2019 · 216 citations · Full text

Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes

Andrea Cortese, Yi Zhu, Adriana Rebelo et al. · Nature Genetics · 2020 · 170 citations · Full text

Biallelic Mutations, Somatic Variant, Genetic Disorder +9

Admission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy

Steven Brooks, Chauncey Spears, Christopher L. Cummings et al. · Journal of NeuroInterventional Surgery · 2013 · 154 citations · Full text